Literature DB >> 8311846

Agonist-induced muscarinic cholinergic receptor internalization, recycling and degradation in cultured neuronal cells. Cellular mechanisms and role in desensitization.

J M Maloteaux1, E Hermans.   

Abstract

Short-term incubation of intact neuronal cells with muscarinic cholinergic agonists resulted in a rapid decrease of the specific binding of [3H]methylscopolamine to cell surface receptors indicative of receptor internalization. The agonists induced the internalization of both the muscarinic receptor subtypes coupled to adenylyl cyclase and those coupled to phosphoinositide turnover. Receptor internalization, which was inhibited at 0-4 degrees and by depletion of intracellular K+, is thought to occur through coated pits formation and was rapidly reversible. Receptor recycling did not imply protein synthesis. Down-regulation of muscarinic receptors occurred slowly in the presence of agonists, needed intact cytoskeleton (demonstrated by the inhibitory effect of colchicine) and involved lysosomal activity. Both receptor internalization and down-regulation were prevented by muscarinic receptor antagonists. Receptor internalization and down-regulation are agonist-induced cellular mechanisms that with receptor phosphorylation and uncoupling, may induce desensitization. These processes may contribute to complex intracellular regulatory processes and may be involved in some of the long-term effects of neurotransmitters (mainly neuropeptides and growth hormones) or drugs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8311846     DOI: 10.1016/0006-2952(94)90439-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  An autonomic link between inhaled diesel exhaust and impaired cardiac performance: insight from treadmill and dobutamine challenges in heart failure-prone rats.

Authors:  Alex P Carll; Mehdi S Hazari; Christina M Perez; Q Todd Krantz; Charly J King; Najwa Haykal-Coates; Wayne E Cascio; Daniel L Costa; Aimen K Farraj
Journal:  Toxicol Sci       Date:  2013-07-19       Impact factor: 4.849

2.  Long-term carbachol treatment-induced down-regulation of muscarinic M2-receptors but not m2 receptor mRNA in a human lung cell line.

Authors:  E B Haddad; J Rousell; J C Mak; P J Barnes
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

3.  Agonists with supraphysiological efficacy at the muscarinic M2 ACh receptor.

Authors:  R Schrage; W K Seemann; J Klöckner; C Dallanoce; K Racké; E Kostenis; M De Amici; U Holzgrabe; K Mohr
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

4.  Immediate and delayed consequences of xanomeline wash-resistant binding at the M3 muscarinic receptor.

Authors:  Meredith J Noetzel; Marianne K O Grant; Esam E El-Fakahany
Journal:  Neurochem Res       Date:  2008-12-12       Impact factor: 3.996

5.  Mechanisms of M3 muscarinic receptor regulation by wash-resistant xanomeline binding.

Authors:  Meredith J Noetzel; Marianne K O Grant; Esam E El-Fakahany
Journal:  Pharmacology       Date:  2009-04-28       Impact factor: 2.547

6.  Acute but not chronic donepezil increases muscarinic receptor-mediated signaling via arachidonic acid in unanesthetized rats.

Authors:  Mireille Basselin; Henry N Nguyen; Lisa Chang; Jane M Bell; Stanley I Rapoport
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  Dynamic distribution of chemoattractant receptors in living cells during chemotaxis and persistent stimulation.

Authors:  Z Xiao; N Zhang; D B Murphy; P N Devreotes
Journal:  J Cell Biol       Date:  1997-10-20       Impact factor: 10.539

8.  Adaptation to prolonged neuromodulation in cortical cultures: an invariable return to network synchrony.

Authors:  Maya Kaufman; Sebastian Reinartz; Noam E Ziv
Journal:  BMC Biol       Date:  2014-10-23       Impact factor: 7.431

Review 9.  Diffusion dynamics of synaptic molecules during inhibitory postsynaptic plasticity.

Authors:  Enrica Maria Petrini; Andrea Barberis
Journal:  Front Cell Neurosci       Date:  2014-09-23       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.